Impact of statin use on oncologic outcomes of patients with upper tract urothelial carcinoma treated with radical nephroureterectomy

European Urology

Volumn 63, Issue 6, 2013, Pages 1134-1135

  Xylinas, Evanguelos ^a,c   Kluth, Luis A ^a,d   Crivelli, Joseph J ^a   Rieken, Malte ^a,e   Margulis, Vitaly ^f   Seitz, Christian ^g   Shariat, Shahrokh F ^a,b,g  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^c Paris Descartes University ^*  (France)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^e UNIVERSITY HOSPITAL BASEL   (Switzerland)

^f UNIVERSITY OF TEXAS AT DALLAS   (United States)

^g MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SPECIFIC SURVIVAL; CAUSE OF DEATH; CLINICAL FEATURE; DRUG USE; FOLLOW UP; HUMAN; LETTER; LYMPH VESSEL METASTASIS; NEPHROURETERECTOMY; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; SMOKING CESSATION; TRANSITIONAL CELL CARCINOMA; TREATMENT OUTCOME;

CARCINOMA, TRANSITIONAL CELL; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPIDEMIAS; KIDNEY NEOPLASMS; KIDNEY PELVIS; MALE; NEPHRECTOMY; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; URETER; URETERAL NEOPLASMS;

EID: 84876479504     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2013.03.027     Document Type: Letter

References (9)

1. S.A. Kamat, S.K. Gandhi, and M. Davidson Comparative effectiveness of rosuvastatin versus other statin therapies in patients at increased risk of failure to achieve low-density lipoprotein goals Curr Med Res Opin 23 2007 1121 1130
2. R.K. Berglund, C.J. Savage, K.C. Vora, J.M. Kurta, and A.M. Cronin An analysis of the effect of statin use on the efficacy of bacillus Calmette-Guerin treatment for transitional cell carcinoma of the bladder J Urol 180 2008 1297 1300 discussion 1300
3. Xylinas E, Rink M, Cha EK, et al. Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo. 2012.04.052.
4. M. Rink, H. Fajkovic, and E.K. Cha Death certificates are valid for the determination of cause of death in patients with upper and lower tract urothelial carcinoma Eur Urol 61 2012 854 855
5. S.F. Nielsen, B.G. Nordestgaard, and S.E. Bojesen Statin use and reduced cancer-related mortality N Engl J Med 367 2012 1792 1802
6. M. Rink, E. Xylinas, and V. Margulis Impact of smoking on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy Eur Urol 63 2013 1082 1090
7. P. Hoffmann, T. Roumeguère, C. Schulman, and R. van Velthoven Use of statins and outcome of BCG treatment for bladder cancer N Engl J Med 355 2006 2705 2707
8. A.M. Kamat, and X. Wu Statins and the effect of BCG on bladder cancer N Engl J Med 356 2007 1276
9. T.A. Skolarus, E.W. Lee, and K.S. Virgo Intravesical bacille Calmette-Guérin therapy for non-muscle-invasive bladder cancer: effects of concurrent statin therapy J Am Coll Surg 209 2009 248 253